1. Home
  2. BGI vs LEXX Comparison

BGI vs LEXX Comparison

Compare BGI & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGI
  • LEXX
  • Stock Information
  • Founded
  • BGI 1879
  • LEXX 2004
  • Country
  • BGI Canada
  • LEXX Canada
  • Employees
  • BGI N/A
  • LEXX N/A
  • Industry
  • BGI
  • LEXX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BGI
  • LEXX Health Care
  • Exchange
  • BGI Nasdaq
  • LEXX Nasdaq
  • Market Cap
  • BGI 18.0M
  • LEXX 19.6M
  • IPO Year
  • BGI 2005
  • LEXX N/A
  • Fundamental
  • Price
  • BGI $0.91
  • LEXX $0.96
  • Analyst Decision
  • BGI
  • LEXX Strong Buy
  • Analyst Count
  • BGI 0
  • LEXX 1
  • Target Price
  • BGI N/A
  • LEXX $7.00
  • AVG Volume (30 Days)
  • BGI 57.4K
  • LEXX 137.9K
  • Earning Date
  • BGI 07-15-2025
  • LEXX 07-11-2025
  • Dividend Yield
  • BGI N/A
  • LEXX N/A
  • EPS Growth
  • BGI N/A
  • LEXX N/A
  • EPS
  • BGI N/A
  • LEXX N/A
  • Revenue
  • BGI $131,596,265.00
  • LEXX $525,923.00
  • Revenue This Year
  • BGI N/A
  • LEXX $0.62
  • Revenue Next Year
  • BGI N/A
  • LEXX $14.19
  • P/E Ratio
  • BGI N/A
  • LEXX N/A
  • Revenue Growth
  • BGI 4.01
  • LEXX 29.95
  • 52 Week Low
  • BGI $0.76
  • LEXX $0.92
  • 52 Week High
  • BGI $2.99
  • LEXX $4.38
  • Technical
  • Relative Strength Index (RSI)
  • BGI 51.08
  • LEXX 40.26
  • Support Level
  • BGI $0.86
  • LEXX $0.94
  • Resistance Level
  • BGI $0.93
  • LEXX $1.05
  • Average True Range (ATR)
  • BGI 0.07
  • LEXX 0.06
  • MACD
  • BGI 0.01
  • LEXX 0.01
  • Stochastic Oscillator
  • BGI 72.29
  • LEXX 21.79

About BGI Birks Group Inc.

Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

Share on Social Networks: